“…Consequently, it is easy to invoke such abnormalities resulting in the loss or inactivation of a critical tumor suppressor protein; however, efforts to determine a culprit gene or cluster of genes have been much more difficult. Characteristic chromosomal abnormalities in MDS include alterations of chromosomes 5,7,8,11,17,20 and Y or complex karyotypes involving multiple abnormalities within individual clonal populations [45,46]. Several of these abnormalities are shared with AML (e.g., deletions of chromosomes 5 or 7, trisomy 8, and complex cytogenetics), while others appear almost exclusively in AML (e.g., t (15; 17), t (8; 21), and inversion 16) [22].…”